AstraZeneca PLC said Thursday that new preliminary data indicate that its Vaxzevria coronavirus vaccine showed increased antibody response to several coronavirus variants after a third dose or booster immunization. ..
Pharmaceutical giants have shown positive results from safety and immunogenicity trials showing that the drug increases the immune response to beta, delta, alpha, and gamma variants of the virus and is generally well tolerated. Said that was obtained. Another analysis of samples from the test also showed an increase in antibody response to the Omicron mutant, the company said.
Results were obtained from individuals previously vaccinated with the Vaxzevria or mRNA vaccine. However, AstraZeneca said in another Phase 4 study, it showed that antibody levels in individuals primarily vaccinated with the Sinovac Biotech Ltd. vaccine CoronaVac were significantly increased with a third dose. .. Regardless of primary vaccination.
“Given the urgency of the pandemic and the increased immune response of the Vaxzevria to the Omicron variant, we will continue to submit it to regulatory agencies worldwide for use as a third booster,” said Biopharmacy R & D. Executive Vice President Mene Pangalos said. ..
Write to Joe Hoppe at firstname.lastname@example.org
AstraZeneca says the coronavirus vaccine shows an increased response on the third dose
Source link AstraZeneca says the coronavirus vaccine shows an increased response on the third dose
The post AstraZeneca says the coronavirus vaccine shows an increased response on the third dose appeared first on Eminetra.